2026 Ep 4 Insights in Homeopathy with Christophe Merville of Boiron

NOV 16, 202657 MIN

Description

Send us Fan Mail Homeopathy is one of those topics that gets dismissed in a sentence or defended with pure belief, and neither approach helps when you’re just trying to get through cold and flu season. We sit down with Christophe Merville, a French-trained pharmacist and Director of Education and Pharmacy Development at Boiron USA, to sort out what homeopathic medicine is actually trying to do, why dilution and potency confuse so many people, and where the evidence conversation stands today. We talk openly about placebo, skepticism, and what counts as meaningful research, including randomized placebo-controlled trials, meta-analyses, and real-world outcomes. Christophe explains homeopathy’s core strategy as supporting the body’s natural process rather than suppressing symptoms, then gives a listener-friendly way to think about low vs high dilutions: local symptoms often call for low potency, while whole-body issues like fever, anxiety, and sleeplessness lean higher. From there we get practical. We break down how ColdCalm aligns with stages of a cold, why dosing can be frequent early on, and how SinusCalm aims to reduce pressure by helping sinus drainage before a problem turns into sinusitis. We also cover AllergyCalm for seasonal and indoor triggers, Arnica vs Calendula for bruising and skin healing, and why Chestal is built for dry cough, coughing fits, and productive mucus. Finally, we unpack Oscillococcinum, its surprising 1918 flu origin story, what studies suggest, and why starting at the first signs matters. We also share common-sense immune support for flu and COVID risk, including vaccination, nutrition, sleep, and gut health. If you want clear guidance without hype, hit play, then subscribe, share the episode with a friend, and leave a review so more people can find the show. Use coupon code "NUTZ" (in your cart) for 15% off your entire order of featured products on our sponsor's website:  HollyHillVitamins.com.